Related Experiment Video
Updated: Aug 18, 2025

Novel In Vivo Micro-Computed Tomography Imaging Techniques for Assessing the Progression of Non-Alcoholic Fatty Liver Disease
Published on: March 24, 2023
Interaction between sarcopenia and nonalcoholic fatty liver disease
Sae Kyung Joo1,2, Won Kim1,2
1Division of Gastroenterology and Hepatology, Department of Internal Medicine, Seoul Metropolitan Government Seoul National University Boramae Medical Center, Seoul, Korea.
Sarcopenia and nonalcoholic fatty liver disease (NAFLD) share common aging-related pathways like inflammation and insulin resistance. Their bidirectional relationship is complex, with ongoing research into causality and impact on nonalcoholic steatohepatitis (NASH).
Area of Science:
- Gerontology
- Hepatology
- Metabolic Diseases
Background:
- Sarcopenia (age-related muscle loss) and nonalcoholic fatty liver disease (NAFLD) are prevalent conditions, particularly in aging populations.
- Existing research indicates a significant association between sarcopenia and NAFLD, despite differing diagnostic criteria.
Purpose of the Study:
- To review the shared pathogenetic mechanisms linking sarcopenia and NAFLD.
- To explore the bidirectional relationship between these two conditions.
Main Methods:
- Literature review of cross-sectional and longitudinal studies.
- Analysis of shared etiological factors and pathophysiological pathways.
Main Results:
- Identified shared mechanisms including insulin resistance, hormonal imbalances, systemic inflammation, and dysregulation of myostatin and adiponectin.
- Highlighted nutritional deficiencies and physical inactivity as contributing factors.
- Acknowledged the bidirectional nature of the sarcopenia-NAFLD link.
Conclusions:
- Sarcopenia and NAFLD are interconnected through multiple common pathways, suggesting a complex interplay.
- Further research is needed to establish a direct causal relationship and clarify the role of sarcopenia in nonalcoholic steatohepatitis (NASH).
Related Concept Videos
Ultrasound II: Endoscopic Ultrasound and FibroScan
Endoscopic Ultrasound (EUS):
Overview of Lipid Metabolism
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
Diseases of the Liver and Gallbladder
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
Metabolic States of the Body: Fasting and Starvation
Overview of Carbohydrate Metabolism
Glucose transport into cells is facilitated by a family of transport proteins called GLUT (Glucose Transporters). GLUT4 is the primary glucose transporter for insulin-stimulated glucose...

